Dr. Anthony Letai, a prominent oncologist from Dana-Farber and a Harvard Medical School professor, has been appointed as the new Director of the National Cancer Institute (NCI). Following a series of reports and confirmations, the announcement has garnered support from colleagues who describe him as an inspired choice for the role. His appointment is part of the ongoing efforts by the current administration to strengthen leadership within the NCI, especially in the fight against cancer.